Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
Stock Summary
Top 10 Correlated ETFs
7447.T
Financial details
Company Rating
Buy
Market Cap
62.75B
Income
3.64B
Revenue
17.15B
Book val./share
866.12
Cash/share
458.71
Dividend
60
Dividend %
3.08%
Employees
518
Optionable
No
Shortable
Yes
Earnings
03 Oct 2022
P/E
17.51
Forward P/E
-
PEG
-3.01
P/S
54.47
P/B
22.52
P/C
4.24
P/FCF
8857.85
Quick Ratio
7.33
Current Ratio
10.54
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
44.07
EPS next Y
-
EPS next Q
-
EPS this Y
5.01%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
0.05%
Revenue last 5Y
0.63%
Revenue Q/Q
30.65%
EPS Q/Q
99.84%
-
-
-
-
SMA20
-6.56%
SMA50
-1%
SMA100
-0.95%
Inst Own
-
Inst Trans
-
ROA
8%
ROE
9%
ROC
0.11%
Gross Margin
45%
Oper. Margin
28%
Profit Margin
21%
Payout
791%
Shs Outstand
32.26M
Shs Float
20.92M
-
-
-
-
Target Price
-
52W Range
1796.0-2614.0
52W High
-25.59%
52W Low
+8.3%
RSI
47.23
Rel Volume
3.52
Avg Volume
52.42K
Volume
184.3K
Perf Week
0%
Perf Month
-6.71%
Perf Quarter
-
Perf Half Y
-6.49%
-
-
-
-
Beta
0.126159
-
-
Volatility
25.48%, 72.58%
Prev Close
2.64%
Price
1945
Change
3.79%
Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-08-31
| Metric | History | 2017-08-31 | 2018-08-31 | 2019-08-31 | 2020-08-31 | 2021-08-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 511.85 | 515.69 | 504.82 | 518.15 | 533.23 | |
| Net income per share | 110.49 | 110.57 | 103.61 | 105.47 | 110.75 | |
| Operating cash flow per share | 119.7 | 120.6 | 103.25 | 110.35 | 135.07 | |
| Free cash flow per share | 116.03 | 93.85 | 96.16 | 104.95 | 127.52 | |
| Cash per share | 684.64 | 719.79 | 756.61 | 778.65 | 846.42 | |
| Book value per share | 1.1K | 1.15K | 1.19K | 1.22K | 1.28K | |
| Tangible book value per share | 1.1K | 1.15K | 1.19K | 1.22K | 1.28K | |
| Share holders equity per share | 1.1K | 1.15K | 1.19K | 1.22K | 1.28K | |
| Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
| Market cap | 94.05B | 90.3B | 76.08B | 97.96B | 86.36B | |
| Enterprise value | 71.29B | 66.37B | 50.92B | 72.31B | 58.48B | |
| P/E ratio | 25.6 | 24.56 | 22.08 | 28.2 | 23.67 | |
| Price to sales ratio | 5.53 | 5.27 | 4.53 | 5.74 | 4.92 | |
| POCF ratio | 23.63 | 22.52 | 22.16 | 26.95 | 19.41 | |
| PFCF ratio | 24.38 | 28.94 | 23.79 | 28.34 | 20.56 | |
| P/B Ratio | 2.57 | 2.35 | 1.92 | 2.44 | 2.05 | |
| PTB ratio | 2.57 | 2.35 | 1.92 | 2.44 | 2.05 | |
| EV to sales | 4.19 | 3.87 | 3.03 | 4.24 | 3.33 | |
| Enterprise value over EBITDA | 12.61 | 11.79 | 9.56 | 13.48 | 10.43 | |
| EV to operating cash flow | 17.91 | 16.55 | 14.83 | 19.89 | 13.15 | |
| EV to free cash flow | 18.48 | 21.27 | 15.93 | 20.92 | 13.92 | |
| Earnings yield | 0.04 | 0.04 | 0.05 | 0.04 | 0.04 | |
| Free cash flow yield | 0.04 | 0.03 | 0.04 | 0.04 | 0.05 | |
| Debt to equity | 0 | 0 | 0 | 0 | 0 | |
| Debt to assets | 0.11 | 0.1 | 0.1 | 0.11 | 0.09 | |
| Net debt to EBITDA | -4.03 | -4.25 | -4.72 | -4.78 | -4.97 | |
| Current ratio | 9.44 | 9.96 | 10.03 | 9.68 | 11.18 | |
| Interest coverage | 0 | 0 | 0 | 0 | 0 | |
| Income quality | 1.08 | 1.09 | 1 | 1.05 | 1.22 | |
| Dividend Yield | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | |
| Payout ratio | 0.45 | 0.54 | 0.58 | 0.57 | 0.54 | |
| Sales general and administrative to revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | -0.03 | -0.22 | -0.07 | -0.05 | -0.06 | |
| Capex to revenue | -0.01 | -0.05 | -0.01 | -0.01 | -0.01 | |
| Capex to depreciation | -0.39 | -3.07 | -0.7 | -0.53 | -0.79 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 1.65K | 1.69K | 1.67K | 1.7K | 1.78K | |
| ROIC | 0.14 | 0.13 | 0.12 | 0.12 | 0.12 | |
| Return on tangible assets | 0.09 | 0.09 | 0.08 | 0.08 | 0.08 | |
| Graham Net | 616.98 | 656.5 | 686.86 | 702.92 | 782.93 | |
| Working capital | 28.9B | 29.98B | 31.56B | 32.22B | 33.98B | |
| Tangible asset value | 0 | 0 | 0 | 0 | 0 | |
| Net current asset value | 27.92B | 29.03B | 30.49B | 31.13B | 32.92B | |
| Invested capital | 0 | 0 | 0 | 0 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 1.51B | 1.51B | 1.52B | 1.59B | 1.44B | |
| Average inventory | 4.47B | 4.51B | 4.56B | 4.63B | 4.62B | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 58.39 | 57.17 | 59.27 | 62.8 | 49.56 | |
| Days of inventory on hand | 176.22 | 176.07 | 182.8 | 182.65 | 177.24 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 6.25 | 6.38 | 6.16 | 5.81 | 7.36 | |
| Inventory turnover | 2.07 | 2.07 | 2 | 2 | 2.06 | |
| ROE | 0.1 | 0.1 | 0.09 | 0.09 | 0.09 | |
| Capex per share | -3.67 | -26.75 | -7.09 | -5.4 | -7.55 |
Quarterly Fundamentals Overview
Last date of statement is 2011-08-31 for Q4
| Metric | History | 2010-08-31 | 2010-11-30 | 2011-02-28 | 2011-05-31 | 2011-08-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 89 | 82.28 | 85.5 | 163.82 | 91.61 | |
| Net income per share | 11.94 | 11.68 | 12.32 | 34.91 | 13.48 | |
| Operating cash flow per share | 70.67 | -5.12 | 15.93 | 6.53 | 71.22 | |
| Free cash flow per share | 69.89 | -6.59 | -66.45 | 5.61 | 70.49 | |
| Cash per share | 494.48 | 454.4 | 384.82 | 390.19 | 458.71 | |
| Book value per share | 826.97 | 806.66 | 818.3 | 853.52 | 866.12 | |
| Tangible book value per share | 825.27 | 804.96 | 816.62 | 851.55 | 863.39 | |
| Share holders equity per share | 826.97 | 806.66 | 818.3 | 853.52 | 866.12 | |
| Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
| Market cap | 34.86B | 33.57B | 35.43B | 38.06B | 39.99B | |
| Enterprise value | 18.22B | 18.43B | 22.39B | 24.84B | 24.41B | |
| P/E ratio | 21.04 | 20.86 | 20.87 | 7.91 | 21.52 | |
| Price to sales ratio | 11.29 | 11.84 | 12.03 | 6.75 | 12.67 | |
| POCF ratio | 14.22 | -190.35 | 64.56 | 169.12 | 16.3 | |
| PFCF ratio | 14.38 | -147.97 | -15.48 | 197.04 | 16.47 | |
| P/B Ratio | 1.22 | 1.21 | 1.26 | 1.29 | 1.34 | |
| PTB ratio | 1.22 | 1.21 | 1.26 | 1.29 | 1.34 | |
| EV to sales | 5.9 | 6.5 | 7.6 | 4.4 | 7.73 | |
| Enterprise value over EBITDA | 23.62 | 24.8 | 28.31 | 11.81 | 28.38 | |
| EV to operating cash flow | 7.43 | -104.52 | 40.8 | 110.36 | 9.95 | |
| EV to free cash flow | 7.52 | -81.25 | -9.78 | 128.59 | 10.05 | |
| Earnings yield | 0.01 | 0.01 | 0.01 | 0.03 | 0.01 | |
| Free cash flow yield | 0.07 | -0.01 | -0.06 | 0.01 | 0.06 | |
| Debt to equity | 0 | 0 | 0 | 0 | 0 | |
| Debt to assets | 0.11 | 0.09 | 0.09 | 0.1 | 0.11 | |
| Net debt to EBITDA | -21.56 | -20.37 | -16.49 | -6.29 | -18.12 | |
| Current ratio | 8.62 | 10.49 | 8.69 | 7.67 | 7.44 | |
| Interest coverage | 0 | 0 | 0 | 0 | 0 | |
| Income quality | 5.92 | -0.44 | 1.29 | 0.19 | 5.28 | |
| Dividend Yield | 0 | 0.03 | 0 | 0 | 0 | |
| Payout ratio | 0 | 2.61 | 0.18 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | -0.01 | 0.29 | -5.17 | -0.14 | -0.01 | |
| Capex to revenue | -0.01 | -0.02 | -0.96 | -0.01 | -0.01 | |
| Capex to depreciation | -0.4 | -0.73 | -41.43 | -0.44 | -0.36 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 471.35 | 460.37 | 476.3 | 818.82 | 512.63 | |
| ROIC | 0.05 | 0.03 | 0.02 | 0.07 | 0.05 | |
| Return on tangible assets | 0.01 | 0.01 | 0.01 | 0.04 | 0.01 | |
| Graham Net | 436.31 | 421.72 | 351.87 | 330.34 | 394.97 | |
| Working capital | 21.66B | 20.78B | 18.39B | 19.65B | 20.21B | |
| Tangible asset value | 28.62B | 27.73B | 28.13B | 29.33B | 29.74B | |
| Net current asset value | 21.09B | 20.25B | 17.86B | 19.16B | 19.65B | |
| Invested capital | 0 | 0 | 0 | 0 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 1.41B | 1.47B | 1.56B | 1.54B | 1.5B | |
| Average inventory | 4.06B | 4.27B | 4.46B | 4.05B | 4.18B | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 66.85 | 81.38 | 89.1 | 45.77 | 76.98 | |
| Days of inventory on hand | 148.14 | 189.05 | 203.77 | 83.32 | 160.2 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 1.35 | 1.11 | 1.01 | 1.97 | 1.17 | |
| Inventory turnover | 0.61 | 0.48 | 0.44 | 1.08 | 0.56 | |
| ROE | 0.01 | 0.01 | 0.02 | 0.04 | 0.02 | |
| Capex per share | -0.78 | -1.47 | -82.38 | -0.93 | -0.73 |
Frequently Asked Questions
What is Nagaileben Co., Ltd. stock symbol ?
Nagaileben Co., Ltd. is a JP stock and trading under the symbol 7447.T
What is Nagaileben Co., Ltd. stock quote today ?
Nagaileben Co., Ltd. stock price is $1945 today.
Is Nagaileben Co., Ltd. stock public?
Yes, Nagaileben Co., Ltd. is a publicly traded company.
Company Profile
- Volume Average 52.42K
- Market Capitalization 62.75B
- Employee 518
- Headquarters Tokyo,JP
- IPO Date 2001-08-10
-
Website
https://www.nagaileben.co.jp 
Nagaileben Co., Ltd. produces and sells medical clothing in Japan. It offers hospital, clinic, and operation room wear products. The company was founded in 1915 and is headquartered in Tokyo, Japan.
